Genomics Market

Global Genomics Market Share, Size, Outlook, Forecast: By Product: Consumables, Systems and Software, Services; By Technology: PCR, Sequencing, Microarray, Others; By Application; By End Use; Regional Analysis; Market Dynamics: SWOT Analysis; Value Chain Analysis; Competitive Landscape; Industry Events and Developments; 2024-2032

Global Genomics Market Outlook

The global genomics market was estimated at USD 21.46 billion in 2023 and is expected to grow at a CAGR of 9.5% over the forecast period of 2024-2032.

 

Global Genomics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The market for genomics is driven by the genomic data pool, which has resulted in the development of the study operations, allowing physicians, biologists, and patients to further explore the genetic predisposition to certain illnesses. It is anticipated that the clinical implementation of this data pool will play a significant part in transforming the healthcare system with regard to providing more precise, efficient, and reliable alternatives for disease management.

 

Global Genomics Market: Properties and Applications

Genomics is referred to as the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.

 

Global Genomics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The genomics market can be divided based on segments like product, technology, application, and end-use.

The genomics industry is broadly divided on the basis of product into:

  • Consumables
  • Systems and Software 
  • Services

Based on technology, the genomics market is divided into:

  • PCR 
  • Sequencing 
  • Microarray 
  • Nucleic Acid Extraction and Purification 
  • Others

The genomics market is segmented on the basis of application into:

  • Diagnostics
  • Drug Discovery and Development
  • Precision Medicine
  • Agriculture and Animal Research
  • Others

Based on end-uses, the genomics market is divided into:

  • Research Centres and Academic and Government Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

The EMR report looks into the regional genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Genomics Market Analysis

The global genomics market is driven by the application of human genetic research in multiple government health programs such as consumer wellness programs, demographic screening, and others. The key objectives of the programs are to optimize preventive care for prevalent chronic diseases such as cancer and heart disease. The growing investment by government agencies, financing departments, and biotechnology firms to accelerate genomic research is expected to have significant implications for the genomics market reshaping. International financing agencies such as NIH and Welcome Trust are committed to offering to finance genetic research, which is supposed to boost genomic research in both advanced and emerging countries, further aiding the global genomics market.

 

Global Genomics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Genomics Market: Competitive Landscape

The report presents a detailed analysis of the following key players in the global genomics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Illumina, Inc. (NASDAQ: ILMN)      
  • Qiagen  
  • Eurofins Scientific  
  • Agilent Technologies, Inc.  
  • Oxford Nanopore Technologies    
  • F. Hoffmann-La Roche  
  • Bio-Rad Laboratories, Inc.  
  • BGI Group
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

Key Highlights of the Report:

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Technology, Application, End Use, Region
Breakup by Product Consumables, Systems and Software, Services
Breakup by Technology PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others
Breakup by Application Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others
Breakup by End Use Research Centres and Academic & Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Illumina, Inc. (NASDAQ: ILMN), Qiagen (NYSE: QGEN), Eurofins Scientific
(EPA: ERF), Agilent Technologies, Inc. (NYSE: A), Oxford Nanopore Technologies,
F. Hoffmann-La Roche (SWX: ROG), Bio-Rad Laboratories, Inc. (NYSE: BIO), BGI Group, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Genomics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Genomics Historical Market (2018-2023) 
    8.3    Global Genomics Market Forecast (2024-2032)
    8.4    Global Genomics Market by Product
        8.4.1    Consumables
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Systems and Software
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Services
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
    8.5    Global Genomics Market by Technology
        8.5.1    PCR
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Sequencing
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Microarray
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Nucleic Acid Extraction and Purification
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Others
    8.6    Global Genomics Market by Application
        8.6.1    Diagnostics
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Drug Discovery and Development
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Precision Medicine
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Agriculture and Animal Research
            8.6.4.1    Historical Trend (2018-2023)
            8.6.4.2    Forecast Trend (2024-2032)
        8.6.5    Others
    8.7    Global Genomics Market by End Use
        8.7.1    Research Centres and Academic and Government Institutes
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Hospitals and Clinics
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Pharmaceutical and Biotechnology Companies
            8.7.3.1    Historical Trend (2018-2023)
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Others    
    8.8    Global Genomics Market by Region
        8.8.1    North America
            8.8.1.1    Historical Trend (2018-2023) 
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Europe
            8.8.2.1    Historical Trend (2018-2023) 
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Asia Pacific
            8.8.3.1    Historical Trend (2018-2023) 
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Latin America
            8.8.4.1    Historical Trend (2018-2023) 
            8.8.4.2    Forecast Trend (2024-2032)
        8.8.5    Middle East and Africa
            8.8.5.1    Historical Trend (2018-2023) 
            8.8.5.2    Forecast Trend (2024-2032) 
9    North America Genomics Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Genomics Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Genomics Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.2    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Genomics  Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa  Genomics Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Illumina, Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    QIAGEN GmbH
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Eurofins GSC Lux SARL
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Agilent Technologies, Inc.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Oxford Nanopore Technologies Limited
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    F. Hoffmann-La Roche
            16.2.6.1    Company Overview
            16.2.6.2    Product Portfolio
            16.2.6.3    Demographic Reach and Achievements
            16.2.6.4    Certifications
        16.2.7    Bio-Rad Laboratories, Inc.
            16.2.7.1    Company Overview
            16.2.7.2    Product Portfolio
            16.2.7.3    Demographic Reach and Achievements
            16.2.7.4    Certifications
        16.2.8    BGI Group
            16.2.8.1    Company Overview
            16.2.8.2    Product Portfolio
            16.2.8.3    Demographic Reach and Achievements
            16.2.8.4    Certifications
        16.2.9    Others
17    Key Trends and   Developments in the Market

 

List of Key Figures and Tables

1.    Global Genomics Market: Key Industry Highlights, 2018 and 2032
2.    Global Genomics Historical Market: Breakup by Product (USD Billion), 2018-2023
3.    Global Genomics Market Forecast: Breakup by Product (USD Billion), 2024-2032
4.    Global Genomics Historical Market: Breakup by Technology (USD Billion), 2018-2023
5.    Global Genomics Market Forecast: Breakup by Technology (USD Billion), 2024-2032
6.    Global Genomics Historical Market: Breakup by Application (USD Billion), 2018-2023
7.    Global Genomics Market Forecast: Breakup by Application (USD Billion), 2024-2032
8.    Global Genomics Historical Market: Breakup by End Use (USD Billion), 2018-2023
9.    Global Genomics Market Forecast: Breakup by End Use (USD Billion), 2024-2032
10.    Global Genomics Historical Market: Breakup by Region (USD Billion), 2018-2023
11.    Global Genomics Market Forecast: Breakup by Region (USD Billion), 2024-2032
12.    North America Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    North America Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Europe Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Europe Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Asia Pacific Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Asia Pacific Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Latin America Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
19.    Latin America Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.    Middle East and Africa Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
21.    Middle East and Africa Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22.    Global Genomics Market Structure

Key Questions Answered in the Report

In 2023, the global genomics market attained a value of nearly USD 21.46 billion.

The market is projected to grow at a CAGR of 9.5% between 2024 and 2032.

The major market drivers include the growing scientific research and innovation focused on genomics, the growing prevalence of cancer, the introduction of government organised consumer wellness programmes, and growing technological advancements.

The key trends guiding the growth of the market include the development in non-invasive cancer screening-based research, growing clinical trials and increased funding for research, and the introduction of favourable government initiatives to advance genomics.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major genomics products in the market include consumables, systems and software, and services.

The significant technologies of genomics considered in the market report include PCR, sequencing, microarray, and nucleic acid extraction and purification, among others.

Diagnostics, drug discovery and development, precision medicine, and agriculture and animal research, among others, are the leading applications of genomics.

The various end uses of genomics include research centres and academic and government institutes, hospitals and clinics, and pharmaceutical and biotechnology companies, among others.

The major players in the market are Illumina, Inc., QIAGEN GmbH, Eurofins GSC Lux SARL, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., and BGI Group, among others.

Analyst Review

The global genomics market attained a value of USD 21.46 billion in 2023, driven by the growing research and clinical trials in the field of genomes. Aided by the technological advancements and increased funding to accelerate genomic research, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9.5%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the genomics industry can be segmented into consumables, systems and software, and services. On the basis of technology, the genomics market is divided into PCR, sequencing, microarray, nucleic acid extraction and purification, and others. On the basis of applications, the industry is divided into diagnostics, drug discovery and development, precision medicine, and agriculture and animal research, among others. Based on end use, the industry is categorised into research centres and academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. The major regional markets for genomics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina, Inc., Qiagen, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., and BGI Group, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER